Enzon Pharmaceuticals, Inc. (BST:EZ1)
Germany flag Germany · Delayed Price · Currency is EUR
0.0615
-0.0140 (-18.54%)
At close: Jul 4, 2025

Enzon Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
7116172215
Upgrade
Market Cap Growth
8.66%78.15%-63.33%-23.37%48.31%85.68%
Upgrade
Enterprise Value
694151711
Upgrade
Last Close Price
0.080.120.07---
Upgrade
PE Ratio
--70.85---
Upgrade
PS Ratio
301.39445.57-704.0436.26354.51
Upgrade
PB Ratio
0.170.260.150.400.540.39
Upgrade
P/TBV Ratio
4.013.851.985.375.222.51
Upgrade
P/OCF Ratio
30.9710.335.32---
Upgrade
EV/Sales Ratio
252.89347.23-597.2727.83252.38
Upgrade
Asset Turnover
0.000.00-0.000.020.00
Upgrade
Quick Ratio
81.1727.9327.4327.65118.29116.93
Upgrade
Current Ratio
82.1728.1027.6227.89118.50117.07
Upgrade
Return on Equity (ROE)
-0.14%1.70%2.99%-0.40%-0.99%-4.87%
Upgrade
Return on Assets (ROA)
-2.71%-1.75%-1.37%-1.35%-0.61%-2.98%
Upgrade
Return on Capital (ROIC)
-2.74%-1.81%-1.42%-1.38%-0.62%-3.03%
Upgrade
Earnings Yield
-17.11%6.72%19.78%-1.02%-1.85%-7.11%
Upgrade
Payout Ratio
-163.88%92.86%---
Upgrade
Buyback Yield / Dilution
-----45.23%-15.57%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.